Trials / Conditions / Node-positive Breast Cancer

Node-positive Breast Cancer

16 registered clinical trials studyying Node-positive Breast Cancer — 9 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Axillary Node Dissection w or w/o LVB in Node Positive Breast Cancer Patients NCT05970107	Case Comprehensive Cancer Center	N/A
Not Yet Recruiting	Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Tri NCT07276880	UNC Lineberger Comprehensive Cancer Center	Phase 2
Recruiting	Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer NCT06833502	H. Lee Moffitt Cancer Center and Research Institute	Phase 2
Recruiting	Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary Surger NCT07085442	University Hospitals of Derby and Burton NHS Foundation Trust	—
Recruiting	Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer NCT06790264	European Institute of Oncology	N/A
Recruiting	Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer NCT06559540	Washington University School of Medicine	Phase 2
Unknown	Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvan NCT05676866	Assiut University	Phase 4
Recruiting	OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk NCT05333328	Gangnam Severance Hospital	Phase 4
Recruiting	TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes NCT05462457	Kliniken Essen-Mitte	—
Completed	Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI NCT04826211	IRCCS San Raffaele	N/A
Unknown	MUltimodal Targeted Axillary Surgery NCT04039893	Parc de Salut Mar	N/A
Recruiting	Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients NCT03513614	University Hospital, Basel, Switzerland	N/A
Active Not Recruiting	Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer NCT02515110	Virginia Commonwealth University	N/A
Completed	Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation NCT02348684	Medical College of Wisconsin	—
Completed	Antioxidant Supplements, Genetics and Chemotherapy Outcomes NCT03413761	Roswell Park Cancer Institute	—
Completed	Randomized Phase II Trial of Dose Dense Docetaxel in N+ Breast Cancer NCT00189670	Association Européenne de Recherche en Oncologie	Phase 2